| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 ITPR1 | 2.44e-12 | 749 | 32 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | Notch binding | 9.29e-08 | 27 | 32 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.06e-06 | 16 | 32 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.88e-06 | 21 | 32 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | structural molecule activity | 7.47e-06 | 891 | 32 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.28e-05 | 268 | 32 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.63e-04 | 12 | 32 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.23e-04 | 188 | 32 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.38e-04 | 85 | 32 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 8.52e-04 | 27 | 32 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 9.83e-04 | 29 | 32 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 9.83e-04 | 29 | 32 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.69e-03 | 323 | 32 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.78e-03 | 39 | 32 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.02e-03 | 51 | 32 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | heparin binding | 3.54e-03 | 192 | 32 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | clathrin binding | 4.57e-03 | 63 | 32 | 2 | GO:0030276 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.51e-09 | 92 | 32 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | axon guidance | 9.50e-09 | 285 | 32 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 9.77e-09 | 286 | 32 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | artery development | 5.07e-08 | 133 | 32 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | LRP1 LRP2 LAMA2 LAMC2 LAMC3 FAT1 NOTCH1 ADAM7 NOTCH3 NOTCH4 SLIT1 ITPR1 | 1.03e-07 | 1194 | 32 | 12 | GO:0000902 |
| GeneOntologyBiologicalProcess | aorta development | 1.43e-07 | 80 | 32 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 4.64e-07 | 41 | 32 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.80e-06 | 566 | 32 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 4.58e-06 | 642 | 32 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.39e-05 | 1269 | 32 | 10 | GO:0009887 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.40e-05 | 4 | 32 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.40e-05 | 748 | 32 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.31e-05 | 802 | 32 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 2.33e-05 | 5 | 32 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.33e-05 | 5 | 32 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.64e-05 | 817 | 32 | 8 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.69e-05 | 819 | 32 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.86e-05 | 826 | 32 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 3.48e-05 | 410 | 32 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 3.48e-05 | 6 | 32 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 3.48e-05 | 6 | 32 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.48e-05 | 6 | 32 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 4.14e-05 | 870 | 32 | 8 | GO:0030855 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 4.87e-05 | 7 | 32 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 4.87e-05 | 7 | 32 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.32e-05 | 134 | 32 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 5.49e-05 | 269 | 32 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.58e-05 | 270 | 32 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 5.95e-05 | 49 | 32 | 3 | GO:0003382 | |
| GeneOntologyBiologicalProcess | blood vessel development | 6.58e-05 | 929 | 32 | 8 | GO:0001568 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 8.34e-05 | 9 | 32 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 8.34e-05 | 9 | 32 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | vasculature development | 8.85e-05 | 969 | 32 | 8 | GO:0001944 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 1.04e-04 | 10 | 32 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.04e-04 | 10 | 32 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.04e-04 | 10 | 32 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.04e-04 | 1285 | 32 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 1.33e-04 | 1327 | 32 | 9 | GO:0040012 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.52e-04 | 67 | 32 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.52e-04 | 12 | 32 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 1.66e-04 | 69 | 32 | 3 | GO:0030857 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.80e-04 | 13 | 32 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | tube development | 2.03e-04 | 1402 | 32 | 9 | GO:0035295 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.04e-04 | 74 | 32 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 2.10e-04 | 14 | 32 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 2.10e-04 | 14 | 32 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.12e-04 | 75 | 32 | 3 | GO:0045109 | |
| GeneOntologyBiologicalProcess | glomerulus development | 2.30e-04 | 77 | 32 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell differentiation | 2.42e-04 | 15 | 32 | 2 | GO:0045602 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 2.42e-04 | 15 | 32 | 2 | GO:0048505 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.48e-04 | 1125 | 32 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion molecule production | 2.76e-04 | 16 | 32 | 2 | GO:0060354 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 2.76e-04 | 16 | 32 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | neuron development | 2.79e-04 | 1463 | 32 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 2.86e-04 | 83 | 32 | 3 | GO:0060976 | |
| GeneOntologyBiologicalProcess | epithelium development | 2.88e-04 | 1469 | 32 | 9 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.97e-04 | 84 | 32 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 3.00e-04 | 210 | 32 | 4 | GO:0007219 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.11e-04 | 212 | 32 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of artery morphogenesis | 3.13e-04 | 17 | 32 | 2 | GO:1905651 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 3.13e-04 | 17 | 32 | 2 | GO:0040034 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 3.40e-04 | 88 | 32 | 3 | GO:0003208 | |
| GeneOntologyBiologicalProcess | hyaluronan catabolic process | 3.51e-04 | 18 | 32 | 2 | GO:0030214 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 3.52e-04 | 89 | 32 | 3 | GO:0060411 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 4.13e-04 | 94 | 32 | 3 | GO:0003151 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 4.13e-04 | 94 | 32 | 3 | GO:0045665 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 4.35e-04 | 20 | 32 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | venous blood vessel development | 4.35e-04 | 20 | 32 | 2 | GO:0060841 | |
| GeneOntologyBiologicalProcess | response to muramyl dipeptide | 4.81e-04 | 21 | 32 | 2 | GO:0032495 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 4.81e-04 | 21 | 32 | 2 | GO:0003215 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 4.81e-04 | 21 | 32 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 4.81e-04 | 99 | 32 | 3 | GO:0045995 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.81e-04 | 99 | 32 | 3 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 4.95e-04 | 100 | 32 | 3 | GO:0045103 | |
| GeneOntologyBiologicalProcess | gliogenesis | 5.13e-04 | 435 | 32 | 5 | GO:0042063 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 5.71e-04 | 105 | 32 | 3 | GO:0048708 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion molecule production | 5.78e-04 | 23 | 32 | 2 | GO:0060353 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 5.87e-04 | 106 | 32 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 5.92e-04 | 1280 | 32 | 8 | GO:2000145 | |
| GeneOntologyBiologicalProcess | regeneration | 5.98e-04 | 252 | 32 | 4 | GO:0031099 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 6.30e-04 | 24 | 32 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 6.30e-04 | 24 | 32 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 6.30e-04 | 24 | 32 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | angiogenesis | 6.76e-04 | 708 | 32 | 6 | GO:0001525 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 7.26e-04 | 114 | 32 | 3 | GO:0008593 | |
| GeneOntologyBiologicalProcess | cell adhesion molecule production | 7.40e-04 | 26 | 32 | 2 | GO:0060352 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 7.66e-04 | 725 | 32 | 6 | GO:2000147 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 8.60e-04 | 28 | 32 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 8.60e-04 | 28 | 32 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 8.60e-04 | 28 | 32 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 8.64e-04 | 742 | 32 | 6 | GO:0040017 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 9.22e-04 | 29 | 32 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 9.87e-04 | 30 | 32 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.05e-03 | 31 | 32 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 1.05e-03 | 31 | 32 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan catabolic process | 1.12e-03 | 32 | 32 | 2 | GO:0006027 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 1.19e-03 | 33 | 32 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 1.27e-03 | 34 | 32 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.29e-03 | 1442 | 32 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 1.42e-03 | 36 | 32 | 2 | GO:1904754 | |
| GeneOntologyCellularComponent | extracellular matrix | 4.86e-06 | 656 | 32 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.98e-06 | 658 | 32 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.34e-04 | 530 | 32 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | apical part of cell | 2.43e-04 | 592 | 32 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.47e-04 | 80 | 32 | 3 | GO:0005905 | |
| GeneOntologyCellularComponent | basement membrane | 8.50e-04 | 122 | 32 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | receptor complex | 1.76e-03 | 581 | 32 | 5 | GO:0043235 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.16e-03 | 45 | 32 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.68e-03 | 384 | 32 | 4 | GO:0030139 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.11e-03 | 212 | 32 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | intermediate filament | 4.97e-03 | 227 | 32 | 3 | GO:0005882 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 5.60e-03 | 237 | 32 | 3 | GO:0030136 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.80e-03 | 477 | 32 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | cell surface | 6.13e-03 | 1111 | 32 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | apical plasma membrane | 6.24e-03 | 487 | 32 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 7.46e-03 | 263 | 32 | 3 | GO:0045111 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.00e-03 | 523 | 32 | 4 | GO:0098984 | |
| MousePheno | opisthotonus | 3.58e-05 | 5 | 27 | 2 | MP:0002880 | |
| MousePheno | abnormal basal lamina morphology | 5.36e-05 | 6 | 27 | 2 | MP:0004273 | |
| MousePheno | absent vestibular hair cells | 9.99e-05 | 8 | 27 | 2 | MP:0004325 | |
| Domain | EGF | LRP1 LRP2 LAMA2 SNED1 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 FCGBP NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 1.32e-24 | 235 | 32 | 17 | SM00181 |
| Domain | EGF-like_dom | LRP1 LRP2 LAMA2 SNED1 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 FCGBP NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 3.63e-24 | 249 | 32 | 17 | IPR000742 |
| Domain | EGF_1 | LRP1 LRP2 LAMA2 SNED1 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 4.49e-22 | 255 | 32 | 16 | PS00022 |
| Domain | EGF-like_CS | LRP1 LRP2 LAMA2 SNED1 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 6.56e-22 | 261 | 32 | 16 | IPR013032 |
| Domain | EGF_2 | LRP1 LRP2 LAMA2 SNED1 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 8.40e-22 | 265 | 32 | 16 | PS01186 |
| Domain | Growth_fac_rcpt_ | LRP1 LRP2 LAMC2 LAMC3 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 1.84e-21 | 156 | 32 | 14 | IPR009030 |
| Domain | EGF_CA | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 6.39e-21 | 122 | 32 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 7.97e-21 | 124 | 32 | 13 | IPR001881 |
| Domain | EGF_Ca-bd_CS | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 3.95e-20 | 97 | 32 | 12 | IPR018097 |
| Domain | EGF_CA | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 5.11e-20 | 99 | 32 | 12 | PS01187 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | LRP1 LRP2 SNED1 EYS FAT1 FBLN5 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 1.35e-17 | 106 | 32 | 11 | IPR000152 |
| Domain | EGF_3 | LRP1 LRP2 SNED1 EYS FAT1 THBS3 FBLN5 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 3.99e-17 | 235 | 32 | 13 | PS50026 |
| Domain | EGF | LRP1 LRP2 SNED1 EYS FAT1 STAB2 NOTCH1 JAG1 NOTCH3 NOTCH4 SLIT1 | 9.66e-17 | 126 | 32 | 11 | PF00008 |
| Domain | ASX_HYDROXYL | 7.14e-16 | 100 | 32 | 10 | PS00010 | |
| Domain | EGF_CA | 1.56e-14 | 86 | 32 | 9 | PF07645 | |
| Domain | hEGF | 2.47e-14 | 28 | 32 | 7 | PF12661 | |
| Domain | NOD | 1.83e-08 | 4 | 32 | 3 | PF06816 | |
| Domain | Notch | 1.83e-08 | 4 | 32 | 3 | IPR008297 | |
| Domain | NODP | 1.83e-08 | 4 | 32 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 1.83e-08 | 4 | 32 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.83e-08 | 4 | 32 | 3 | IPR010660 | |
| Domain | NOD | 1.83e-08 | 4 | 32 | 3 | SM01338 | |
| Domain | NODP | 1.83e-08 | 4 | 32 | 3 | SM01339 | |
| Domain | LNR | 4.56e-08 | 5 | 32 | 3 | PS50258 | |
| Domain | Laminin_G | 4.57e-08 | 58 | 32 | 5 | IPR001791 | |
| Domain | EGF_extracell | 5.44e-08 | 60 | 32 | 5 | IPR013111 | |
| Domain | EGF_2 | 5.44e-08 | 60 | 32 | 5 | PF07974 | |
| Domain | Notch_dom | 1.59e-07 | 7 | 32 | 3 | IPR000800 | |
| Domain | Notch | 1.59e-07 | 7 | 32 | 3 | PF00066 | |
| Domain | NL | 1.59e-07 | 7 | 32 | 3 | SM00004 | |
| Domain | EGF_LAM_2 | 1.88e-07 | 30 | 32 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.88e-07 | 30 | 32 | 4 | PS01248 | |
| Domain | LAMININ_IVA | 2.54e-07 | 8 | 32 | 3 | PS51115 | |
| Domain | Laminin_B | 2.54e-07 | 8 | 32 | 3 | PF00052 | |
| Domain | LamB | 2.54e-07 | 8 | 32 | 3 | SM00281 | |
| Domain | Laminin_IV | 2.54e-07 | 8 | 32 | 3 | IPR000034 | |
| Domain | EGF_Lam | 3.58e-07 | 35 | 32 | 4 | SM00180 | |
| Domain | LAM_G_DOMAIN | 5.03e-07 | 38 | 32 | 4 | PS50025 | |
| Domain | Laminin_EGF | 5.03e-07 | 38 | 32 | 4 | IPR002049 | |
| Domain | - | 5.53e-07 | 95 | 32 | 5 | 2.60.120.200 | |
| Domain | Laminin_G_2 | 6.21e-07 | 40 | 32 | 4 | PF02210 | |
| Domain | Fol_N | 7.47e-07 | 11 | 32 | 3 | IPR003645 | |
| Domain | FOLN | 7.47e-07 | 11 | 32 | 3 | SM00274 | |
| Domain | LamG | 9.18e-07 | 44 | 32 | 4 | SM00282 | |
| Domain | DUF3454 | 8.52e-06 | 3 | 32 | 2 | PF11936 | |
| Domain | DUF3454_notch | 8.52e-06 | 3 | 32 | 2 | IPR024600 | |
| Domain | DUF3454 | 8.52e-06 | 3 | 32 | 2 | SM01334 | |
| Domain | cEGF | 1.16e-05 | 26 | 32 | 3 | IPR026823 | |
| Domain | cEGF | 1.16e-05 | 26 | 32 | 3 | PF12662 | |
| Domain | Laminin_EGF | 2.88e-05 | 35 | 32 | 3 | PF00053 | |
| Domain | ConA-like_dom | 3.29e-05 | 219 | 32 | 5 | IPR013320 | |
| Domain | Keratin_I | 5.77e-05 | 44 | 32 | 3 | IPR002957 | |
| Domain | Laminin_G_1 | 1.55e-04 | 11 | 32 | 2 | PF00054 | |
| Domain | Intermediate_filament_CS | 1.69e-04 | 63 | 32 | 3 | IPR018039 | |
| Domain | Filament | 2.41e-04 | 71 | 32 | 3 | SM01391 | |
| Domain | IF | 2.51e-04 | 72 | 32 | 3 | PS00226 | |
| Domain | Ldl_recept_b | 2.55e-04 | 14 | 32 | 2 | PF00058 | |
| Domain | LDLRB | 2.55e-04 | 14 | 32 | 2 | PS51120 | |
| Domain | TIL_dom | 2.55e-04 | 14 | 32 | 2 | IPR002919 | |
| Domain | Filament | 2.62e-04 | 73 | 32 | 3 | PF00038 | |
| Domain | LY | 2.94e-04 | 15 | 32 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.94e-04 | 15 | 32 | 2 | IPR000033 | |
| Domain | IF | 2.95e-04 | 76 | 32 | 3 | IPR001664 | |
| Domain | LAMININ_NTER | 3.36e-04 | 16 | 32 | 2 | PS51117 | |
| Domain | Laminin_N | 3.36e-04 | 16 | 32 | 2 | PF00055 | |
| Domain | Laminin_N | 3.36e-04 | 16 | 32 | 2 | IPR008211 | |
| Domain | LamNT | 3.36e-04 | 16 | 32 | 2 | SM00136 | |
| Domain | VWC_out | 4.78e-04 | 19 | 32 | 2 | SM00215 | |
| Domain | VWC | 1.92e-03 | 38 | 32 | 2 | SM00214 | |
| Domain | - | 2.03e-03 | 39 | 32 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.13e-03 | 40 | 32 | 2 | IPR023415 | |
| Domain | VWF_dom | 2.35e-03 | 42 | 32 | 2 | IPR001007 | |
| Domain | Ldl_recept_a | 2.69e-03 | 45 | 32 | 2 | PF00057 | |
| Domain | - | 2.81e-03 | 46 | 32 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.81e-03 | 46 | 32 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 3.05e-03 | 48 | 32 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.18e-03 | 49 | 32 | 2 | IPR002172 | |
| Domain | LDLa | 3.18e-03 | 49 | 32 | 2 | SM00192 | |
| Domain | LDLRA_2 | 3.18e-03 | 49 | 32 | 2 | PS50068 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.07e-09 | 12 | 29 | 4 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.02e-08 | 13 | 29 | 4 | M47423 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 7.81e-08 | 5 | 29 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.81e-08 | 5 | 29 | 3 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.56e-07 | 6 | 29 | 3 | M27068 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.45e-07 | 27 | 29 | 4 | M39545 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.72e-07 | 7 | 29 | 3 | MM14734 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 9.10e-07 | 37 | 29 | 4 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.13e-06 | 39 | 29 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.28e-06 | 11 | 29 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.70e-06 | 12 | 29 | 3 | M47533 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.03e-06 | 45 | 29 | 4 | M39571 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.21e-06 | 13 | 29 | 3 | M47534 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.22e-06 | 46 | 29 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.42e-06 | 47 | 29 | 4 | M7946 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 4.31e-06 | 16 | 29 | 3 | M47424 | |
| Pathway | PID_NOTCH_PATHWAY | 6.08e-06 | 59 | 29 | 4 | M17 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 6.26e-06 | 18 | 29 | 3 | M614 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 6.95e-06 | 61 | 29 | 4 | M39540 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.35e-05 | 23 | 29 | 3 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.54e-05 | 24 | 29 | 3 | M11190 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.26e-05 | 82 | 29 | 4 | MM15922 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.48e-05 | 28 | 29 | 3 | M6177 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.49e-05 | 84 | 29 | 4 | M7098 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.06e-05 | 30 | 29 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.06e-05 | 30 | 29 | 3 | M27216 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 4.49e-05 | 34 | 29 | 3 | M39390 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 5.80e-05 | 37 | 29 | 3 | M45513 | |
| Pathway | WP_CANCER_PATHWAYS | 5.85e-05 | 507 | 29 | 7 | M48302 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.92e-05 | 41 | 29 | 3 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 8.53e-05 | 7 | 29 | 2 | M27199 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 9.42e-05 | 118 | 29 | 4 | M39852 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.12e-04 | 46 | 29 | 3 | M239 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.35e-04 | 49 | 29 | 3 | M618 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.22e-04 | 11 | 29 | 2 | M27882 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.22e-04 | 11 | 29 | 2 | M158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.36e-04 | 59 | 29 | 3 | M27218 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.12e-04 | 161 | 29 | 4 | M39770 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.30e-04 | 300 | 29 | 5 | M610 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.59e-04 | 68 | 29 | 3 | M27303 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.66e-04 | 14 | 29 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 4.22e-04 | 15 | 29 | 2 | M27202 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.24e-04 | 72 | 29 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.42e-04 | 73 | 29 | 3 | MM15906 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 5.45e-04 | 17 | 29 | 2 | M666 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 5.45e-04 | 17 | 29 | 2 | M39443 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 5.45e-04 | 17 | 29 | 2 | MM14864 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 5.45e-04 | 17 | 29 | 2 | M39389 | |
| Pathway | WP_FOCAL_ADHESION | 5.49e-04 | 187 | 29 | 4 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.57e-04 | 79 | 29 | 3 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 6.21e-04 | 82 | 29 | 3 | M594 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 6.67e-04 | 84 | 29 | 3 | M3228 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.84e-04 | 19 | 29 | 2 | MM15594 | |
| Pathway | WP_FOCAL_ADHESION | 6.94e-04 | 199 | 29 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.94e-04 | 199 | 29 | 4 | M7253 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.39e-04 | 87 | 29 | 3 | MM15351 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.59e-04 | 20 | 29 | 2 | M27881 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 9.84e-04 | 96 | 29 | 3 | M39834 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.01e-03 | 97 | 29 | 3 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.14e-03 | 101 | 29 | 3 | M39448 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.19e-03 | 25 | 29 | 2 | M27880 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.19e-03 | 25 | 29 | 2 | M27879 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.52e-03 | 246 | 29 | 4 | M10189 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.72e-03 | 30 | 29 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.72e-03 | 30 | 29 | 2 | MM15812 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.83e-03 | 119 | 29 | 3 | M607 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.83e-03 | 31 | 29 | 2 | M592 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.07e-03 | 33 | 29 | 2 | M39503 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.30e-03 | 129 | 29 | 3 | M27649 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.08e-03 | 143 | 29 | 3 | M27275 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.21e-03 | 302 | 29 | 4 | M39719 | |
| Pathway | REACTOME_KERATINIZATION | 3.72e-03 | 153 | 29 | 3 | MM15343 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.79e-03 | 154 | 29 | 3 | M39739 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.83e-03 | 45 | 29 | 2 | MM15344 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 4.17e-03 | 47 | 29 | 2 | M236 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.21e-03 | 532 | 29 | 5 | M27870 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.22e-03 | 326 | 29 | 4 | MM15917 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.35e-03 | 48 | 29 | 2 | M27642 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.85e-03 | 339 | 29 | 4 | M39736 | |
| Pathway | PID_TAP63_PATHWAY | 5.47e-03 | 54 | 29 | 2 | M256 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 6.08e-03 | 57 | 29 | 2 | M48326 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 6.29e-03 | 58 | 29 | 2 | M29616 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 6.50e-03 | 59 | 29 | 2 | M46460 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.72e-03 | 60 | 29 | 2 | MM14872 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 6.80e-03 | 190 | 29 | 3 | MM15687 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.08e-03 | 66 | 29 | 2 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.08e-03 | 66 | 29 | 2 | M18 | |
| Pathway | REACTOME_KERATINIZATION | 9.79e-03 | 217 | 29 | 3 | M27640 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.01e-02 | 74 | 29 | 2 | M39857 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.01e-02 | 74 | 29 | 2 | MM15962 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.01e-02 | 74 | 29 | 2 | M616 | |
| Pubmed | 2.95e-12 | 5 | 32 | 4 | 15882997 | ||
| Pubmed | 2.95e-12 | 5 | 32 | 4 | 20554499 | ||
| Pubmed | 8.84e-12 | 6 | 32 | 4 | 17822320 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 8.84e-12 | 6 | 32 | 4 | 12244553 | |
| Pubmed | 2.06e-11 | 7 | 32 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.06e-11 | 7 | 32 | 4 | 12846471 | |
| Pubmed | 4.12e-11 | 8 | 32 | 4 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 4.12e-11 | 8 | 32 | 4 | 12242716 | |
| Pubmed | 4.12e-11 | 8 | 32 | 4 | 9858718 | ||
| Pubmed | 7.41e-11 | 9 | 32 | 4 | 11118901 | ||
| Pubmed | 7.41e-11 | 9 | 32 | 4 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.23e-10 | 10 | 32 | 4 | 23665443 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.94e-10 | 11 | 32 | 4 | 15499562 | |
| Pubmed | 1.94e-10 | 11 | 32 | 4 | 10878608 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.94e-10 | 11 | 32 | 4 | 9187150 | |
| Pubmed | 1.94e-10 | 11 | 32 | 4 | 12866128 | ||
| Pubmed | 2.91e-10 | 12 | 32 | 4 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.19e-10 | 13 | 32 | 4 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 4.19e-10 | 13 | 32 | 4 | 20558824 | |
| Pubmed | 5.87e-10 | 14 | 32 | 4 | 28192800 | ||
| Pubmed | 5.87e-10 | 14 | 32 | 4 | 14757642 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 7.07e-10 | 3 | 32 | 3 | 25846406 | |
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 26341090 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 14988227 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 15939383 | ||
| Pubmed | 8.00e-10 | 15 | 32 | 4 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.07e-09 | 16 | 32 | 4 | 12617809 | |
| Pubmed | 1.07e-09 | 16 | 32 | 4 | 10842072 | ||
| Pubmed | 1.07e-09 | 16 | 32 | 4 | 17273555 | ||
| Pubmed | 1.39e-09 | 17 | 32 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.39e-09 | 17 | 32 | 4 | 15821257 | |
| Pubmed | 1.79e-09 | 18 | 32 | 4 | 18093989 | ||
| Pubmed | 1.79e-09 | 18 | 32 | 4 | 15689374 | ||
| Pubmed | 2.26e-09 | 19 | 32 | 4 | 16518823 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 2.83e-09 | 4 | 32 | 3 | 28061457 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 24145721 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 2.83e-09 | 4 | 32 | 3 | 19404845 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 28669409 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 10551863 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 11466531 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 24151014 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 17984306 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 20819128 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 11401408 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 2.83e-09 | 4 | 32 | 3 | 10194420 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 2.83e-09 | 4 | 32 | 3 | 8898100 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 36376768 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 2.83e-09 | 4 | 32 | 3 | 18184405 | |
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 2.83e-09 | 4 | 32 | 3 | 20040020 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 2.83e-09 | 4 | 32 | 3 | 15917835 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 2.83e-09 | 4 | 32 | 3 | 17920003 | |
| Pubmed | 3.49e-09 | 21 | 32 | 4 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 3.49e-09 | 21 | 32 | 4 | 14702043 | |
| Pubmed | 5.16e-09 | 23 | 32 | 4 | 14701881 | ||
| Pubmed | 5.16e-09 | 23 | 32 | 4 | 36239412 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 6.19e-09 | 24 | 32 | 4 | 21420948 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 7.07e-09 | 5 | 32 | 3 | 11006133 | |
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 7.07e-09 | 5 | 32 | 3 | 15064243 | |
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 23675950 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 21602525 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 11101851 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 27118257 | ||
| Pubmed | 8.70e-09 | 26 | 32 | 4 | 25446530 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 8.70e-09 | 26 | 32 | 4 | 19369401 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.02e-08 | 27 | 32 | 4 | 21791528 | |
| Pubmed | 1.19e-08 | 28 | 32 | 4 | 19914171 | ||
| Pubmed | 1.38e-08 | 29 | 32 | 4 | 25535917 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.38e-08 | 29 | 32 | 4 | 21402740 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 9111338 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 20870902 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 22526456 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 19503073 | ||
| Pubmed | Whn and mHa3 are components of the genetic hierarchy controlling hair follicle differentiation. | 1.41e-08 | 6 | 32 | 3 | 10559501 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 1.41e-08 | 6 | 32 | 3 | 19603167 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 7835890 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 18299578 | ||
| Pubmed | Notch4 reveals a novel mechanism regulating Notch signal transduction. | 1.41e-08 | 6 | 32 | 3 | 24667410 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 9108364 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 1.41e-08 | 6 | 32 | 3 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 1.41e-08 | 6 | 32 | 3 | 22615412 | |
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 1.41e-08 | 6 | 32 | 3 | 21991352 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.59e-08 | 30 | 32 | 4 | 24552588 | |
| Pubmed | 1.82e-08 | 31 | 32 | 4 | 37573008 | ||
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 10383933 | ||
| Pubmed | Impaired expression of Notch signaling genes in aged human skeletal muscle. | 2.47e-08 | 7 | 32 | 3 | 17301032 | |
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 2.47e-08 | 7 | 32 | 3 | 11518718 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 2.47e-08 | 7 | 32 | 3 | 24711412 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 2.47e-08 | 7 | 32 | 3 | 11344305 | |
| Pubmed | 2.68e-08 | 34 | 32 | 4 | 17015435 | ||
| Pubmed | 2.68e-08 | 34 | 32 | 4 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 3.03e-08 | 35 | 32 | 4 | 21252157 | |
| Pubmed | 3.81e-08 | 37 | 32 | 4 | 24673559 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 3.95e-08 | 8 | 32 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 3.95e-08 | 8 | 32 | 3 | 15465493 | |
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 11044610 | ||
| Pubmed | 5.83e-08 | 41 | 32 | 4 | 22675208 | ||
| Interaction | NTN5 interactions | 5.44e-08 | 24 | 32 | 4 | int:NTN5 | |
| Interaction | FBXO2 interactions | 1.92e-07 | 411 | 32 | 8 | int:FBXO2 | |
| Interaction | HOXA1 interactions | 1.16e-06 | 356 | 32 | 7 | int:HOXA1 | |
| Interaction | ZFP41 interactions | 1.95e-06 | 57 | 32 | 4 | int:ZFP41 | |
| Interaction | MAML2 interactions | 2.44e-06 | 17 | 32 | 3 | int:MAML2 | |
| Interaction | MAML3 interactions | 4.07e-06 | 20 | 32 | 3 | int:MAML3 | |
| Interaction | IGFL3 interactions | 5.88e-06 | 75 | 32 | 4 | int:IGFL3 | |
| Interaction | EGFL7 interactions | 6.53e-06 | 77 | 32 | 4 | int:EGFL7 | |
| Interaction | APBB1 interactions | 1.31e-05 | 195 | 32 | 5 | int:APBB1 | |
| Interaction | PC interactions | 1.38e-05 | 197 | 32 | 5 | int:PC | |
| Interaction | ZNF74 interactions | 2.10e-05 | 34 | 32 | 3 | int:ZNF74 | |
| Interaction | DLK2 interactions | 2.51e-05 | 36 | 32 | 3 | int:DLK2 | |
| Interaction | NOTCH3 interactions | 2.99e-05 | 113 | 32 | 4 | int:NOTCH3 | |
| Interaction | DLL4 interactions | 3.65e-05 | 6 | 32 | 2 | int:DLL4 | |
| Interaction | JAG1 interactions | 3.72e-05 | 41 | 32 | 3 | int:JAG1 | |
| Interaction | THBS1 interactions | 4.72e-05 | 127 | 32 | 4 | int:THBS1 | |
| Interaction | TTLL5 interactions | 6.38e-05 | 49 | 32 | 3 | int:TTLL5 | |
| Interaction | LPA interactions | 1.33e-04 | 11 | 32 | 2 | int:LPA | |
| Interaction | MAML1 interactions | 2.10e-04 | 73 | 32 | 3 | int:MAML1 | |
| Interaction | ATN1 interactions | 2.11e-04 | 187 | 32 | 4 | int:ATN1 | |
| Interaction | IGSF5 interactions | 2.20e-04 | 14 | 32 | 2 | int:IGSF5 | |
| Interaction | CUBN interactions | 2.53e-04 | 15 | 32 | 2 | int:CUBN | |
| Interaction | MTO1 interactions | 2.85e-04 | 81 | 32 | 3 | int:MTO1 | |
| Interaction | SCN3A interactions | 2.89e-04 | 16 | 32 | 2 | int:SCN3A | |
| Interaction | MKRN2 interactions | 3.26e-04 | 385 | 32 | 5 | int:MKRN2 | |
| Interaction | PSEN2 interactions | 3.40e-04 | 86 | 32 | 3 | int:PSEN2 | |
| Interaction | LTBP1 interactions | 4.15e-04 | 92 | 32 | 3 | int:LTBP1 | |
| Interaction | ZNF224 interactions | 4.56e-04 | 20 | 32 | 2 | int:ZNF224 | |
| Interaction | NOTCH4 interactions | 5.03e-04 | 21 | 32 | 2 | int:NOTCH4 | |
| Interaction | CASR interactions | 5.53e-04 | 22 | 32 | 2 | int:CASR | |
| Interaction | DTX4 interactions | 5.53e-04 | 22 | 32 | 2 | int:DTX4 | |
| Interaction | DAB1 interactions | 6.45e-04 | 107 | 32 | 3 | int:DAB1 | |
| Interaction | RBPJ interactions | 6.71e-04 | 254 | 32 | 4 | int:RBPJ | |
| Interaction | JAG2 interactions | 6.99e-04 | 110 | 32 | 3 | int:JAG2 | |
| Cytoband | 17q12-q21 | 2.30e-04 | 32 | 32 | 2 | 17q12-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.18e-04 | 473 | 32 | 4 | chr17q21 | |
| Cytoband | 17q21.2 | 1.10e-03 | 70 | 32 | 2 | 17q21.2 | |
| GeneFamily | Laminin subunits | 5.10e-07 | 12 | 25 | 3 | 626 | |
| GeneFamily | Keratins, type I | 7.48e-06 | 28 | 25 | 3 | 608 | |
| GeneFamily | Low density lipoprotein receptors | 1.42e-04 | 13 | 25 | 2 | 634 | |
| GeneFamily | Ankyrin repeat domain containing | 4.38e-03 | 242 | 25 | 3 | 403 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.66e-02 | 394 | 25 | 3 | 471 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.64e-11 | 196 | 32 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.12e-09 | 275 | 32 | 8 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.82e-09 | 191 | 32 | 7 | MM17059 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.29e-09 | 16 | 32 | 4 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.29e-09 | 16 | 32 | 4 | MM1296 | |
| Coexpression | NABA_CORE_MATRISOME | 3.08e-08 | 270 | 32 | 7 | MM17057 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 3.46e-07 | 233 | 32 | 6 | M13273 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.10e-06 | 505 | 32 | 7 | M39167 | |
| Coexpression | NABA_MATRISOME | 2.59e-06 | 1026 | 32 | 9 | M5889 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 3.31e-06 | 780 | 32 | 8 | M2324 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 4.18e-06 | 805 | 32 | 8 | MM1067 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 4.67e-06 | 365 | 32 | 6 | M39018 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 4.95e-06 | 93 | 32 | 4 | M18750 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 6.51e-06 | 600 | 32 | 7 | M39055 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 8.00e-06 | 32 | 32 | 3 | M5903 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 1.05e-05 | 35 | 32 | 3 | M16637 | |
| Coexpression | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS | 1.25e-05 | 37 | 32 | 3 | M12802 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.48e-05 | 681 | 32 | 7 | M39175 | |
| Coexpression | JAEGER_METASTASIS_DN | 1.49e-05 | 260 | 32 | 5 | M10702 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.58e-05 | 40 | 32 | 3 | M5887 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 1.84e-05 | 42 | 32 | 3 | M5895 | |
| Coexpression | NABA_MATRISOME | 2.15e-05 | 1008 | 32 | 8 | MM17056 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.02e-05 | 8 | 32 | 2 | M9884 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 6.00e-05 | 574 | 32 | 6 | M39056 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN | 9.81e-05 | 199 | 32 | 4 | M2921 | |
| Coexpression | GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN | 1.00e-04 | 200 | 32 | 4 | M6791 | |
| Coexpression | GSE17721_LPS_VS_CPG_1H_BMDC_DN | 1.00e-04 | 200 | 32 | 4 | M3987 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.00e-04 | 200 | 32 | 4 | M6626 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.00e-04 | 200 | 32 | 4 | M5930 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.00e-04 | 200 | 32 | 4 | M5915 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.79e-04 | 439 | 32 | 5 | M39054 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.60e-04 | 1074 | 32 | 7 | M1941 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 2.61e-04 | 102 | 32 | 3 | M14455 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.71e-04 | 20 | 32 | 2 | MM17053 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 2.75e-04 | 482 | 32 | 5 | M12144 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.77e-04 | 261 | 32 | 4 | M1834 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 3.09e-04 | 108 | 32 | 3 | M1281 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.60e-04 | 23 | 32 | 2 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 3.92e-04 | 286 | 32 | 4 | M45746 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 4.01e-04 | 118 | 32 | 3 | MM536 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 4.26e-04 | 25 | 32 | 2 | M47986 | |
| Coexpression | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN | 4.26e-04 | 25 | 32 | 2 | M15380 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 4.26e-04 | 25 | 32 | 2 | M9946 | |
| Coexpression | CHEN_ETV5_TARGETS_SERTOLI | 4.26e-04 | 25 | 32 | 2 | M1586 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.88e-04 | 303 | 32 | 4 | M39040 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 4.97e-04 | 27 | 32 | 2 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 4.97e-04 | 27 | 32 | 2 | MM1135 | |
| Coexpression | CHEN_ETV5_TARGETS_SERTOLI | 5.74e-04 | 29 | 32 | 2 | MM675 | |
| Coexpression | GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN | 6.20e-04 | 137 | 32 | 3 | M429 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 7.17e-04 | 144 | 32 | 3 | M2535 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 8.82e-04 | 355 | 32 | 4 | M45758 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 9.29e-04 | 630 | 32 | 5 | MM1038 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 9.48e-04 | 362 | 32 | 4 | M39176 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 9.67e-04 | 364 | 32 | 4 | M39057 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.03e-03 | 163 | 32 | 3 | M12112 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 3.91e-05 | 1166 | 32 | 9 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.16e-05 | 453 | 32 | 6 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.29e-05 | 455 | 32 | 6 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.41e-05 | 295 | 32 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.11e-04 | 62 | 32 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.46e-07 | 192 | 32 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-07 | 192 | 32 | 5 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-07 | 192 | 32 | 5 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-07 | 193 | 32 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-07 | 193 | 32 | 5 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-07 | 195 | 32 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-07 | 195 | 32 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 196 | 32 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 196 | 32 | 5 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 196 | 32 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 196 | 32 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 196 | 32 | 5 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 196 | 32 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-07 | 197 | 32 | 5 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-07 | 198 | 32 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.02e-07 | 200 | 32 | 5 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.02e-07 | 200 | 32 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.02e-07 | 200 | 32 | 5 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.02e-07 | 200 | 32 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 115 | 32 | 4 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 115 | 32 | 4 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 115 | 32 | 4 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.18e-06 | 129 | 32 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 156 | 32 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.38e-06 | 162 | 32 | 4 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-06 | 169 | 32 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-06 | 169 | 32 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-06 | 169 | 32 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-06 | 171 | 32 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-06 | 171 | 32 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 172 | 32 | 4 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.82e-06 | 172 | 32 | 4 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.82e-06 | 172 | 32 | 4 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 172 | 32 | 4 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 176 | 32 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 176 | 32 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.64e-06 | 177 | 32 | 4 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.64e-06 | 177 | 32 | 4 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.64e-06 | 177 | 32 | 4 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.64e-06 | 177 | 32 | 4 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.34e-06 | 181 | 32 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-06 | 181 | 32 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-06 | 181 | 32 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.34e-06 | 181 | 32 | 4 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-06 | 182 | 32 | 4 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-06 | 182 | 32 | 4 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-06 | 182 | 32 | 4 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.71e-06 | 183 | 32 | 4 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-06 | 183 | 32 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.90e-06 | 184 | 32 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.90e-06 | 184 | 32 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.90e-06 | 184 | 32 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 185 | 32 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.09e-06 | 185 | 32 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 186 | 32 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.29e-06 | 186 | 32 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-06 | 186 | 32 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.49e-06 | 187 | 32 | 4 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.69e-06 | 188 | 32 | 4 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.69e-06 | 188 | 32 | 4 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-06 | 188 | 32 | 4 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.69e-06 | 188 | 32 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-06 | 189 | 32 | 4 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 189 | 32 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 189 | 32 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.89e-06 | 189 | 32 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 189 | 32 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-06 | 189 | 32 | 4 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-06 | 189 | 32 | 4 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-06 | 189 | 32 | 4 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.01e-05 | 190 | 32 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 32 | 4 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 190 | 32 | 4 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 1f660ea2841324d13f63e01f1789e606c2843fc4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 191 | 32 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 191 | 32 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 191 | 32 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 191 | 32 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 191 | 32 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-05 | 191 | 32 | 4 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.03e-05 | 191 | 32 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| Drug | AC1L1G72 | 4.13e-07 | 11 | 32 | 3 | CID000003553 | |
| Drug | AC1L1I0J | 2.41e-06 | 19 | 32 | 3 | CID000004371 | |
| Drug | LMWH | 2.81e-06 | 663 | 32 | 8 | CID000000772 | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.49e-06 | 196 | 32 | 5 | 4655_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 3744_UP | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.06e-06 | 199 | 32 | 5 | 4400_UP | |
| Drug | butyrate | 8.20e-06 | 767 | 32 | 8 | CID000000264 | |
| Drug | AC1L1B58 | 8.99e-06 | 29 | 32 | 3 | CID000001288 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 1.17e-05 | 373 | 32 | 6 | ctd:C540355 | |
| Drug | Vistar | 1.74e-05 | 36 | 32 | 3 | CID000040896 | |
| Drug | Calcort | 2.06e-05 | 38 | 32 | 3 | CID000026709 | |
| Drug | sulfur mustard | 3.22e-05 | 130 | 32 | 4 | CID000010461 | |
| Drug | 9-(5',5'-difluoro-5'-phosphonopentyl)guanine | 3.67e-05 | 46 | 32 | 3 | CID000448999 | |
| Drug | abrine | 4.53e-05 | 285 | 32 | 5 | ctd:C496492 | |
| Drug | NSC34533 | 5.96e-05 | 54 | 32 | 3 | CID000003512 | |
| Drug | kalinin | 6.30e-05 | 55 | 32 | 3 | CID000032518 | |
| Drug | coprogen | 6.85e-05 | 9 | 32 | 2 | CID006323272 | |
| Drug | CC270 | 7.77e-05 | 59 | 32 | 3 | CID006918852 | |
| Drug | LG 5 | 8.17e-05 | 60 | 32 | 3 | CID011840957 | |
| Drug | 2,2'-biphenol | 8.55e-05 | 10 | 32 | 2 | CID000015731 | |
| Drug | 25-azacoprostane | 8.55e-05 | 10 | 32 | 2 | CID000162243 | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 8.55e-05 | 10 | 32 | 2 | ctd:C028145 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 180 | 32 | 4 | 7356_UP | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.19e-04 | 182 | 32 | 4 | 6331_UP | |
| Drug | Korean red ginseng | 1.25e-04 | 12 | 32 | 2 | CID000420552 | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.32e-04 | 187 | 32 | 4 | 7402_DN | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.38e-04 | 189 | 32 | 4 | 2832_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 6498_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 4791_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 4676_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 6660_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4829_UP | |
| Drug | dysprosium | 1.53e-04 | 74 | 32 | 3 | CID000023912 | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 5608_UP | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 4234_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 6673_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 6338_UP | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | 1.62e-04 | 197 | 32 | 4 | 435_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4403_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 5006_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 2256_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4410_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 6347_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4412_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4492_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 5635_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 4399_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 2109_UP | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6521_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 4197_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 2987_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3240_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3827_DN | |
| Drug | 2-amino-5-methylpyridine | 1.72e-04 | 77 | 32 | 3 | CID000015348 | |
| Drug | YIGSR | 1.85e-04 | 79 | 32 | 3 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 2.15e-04 | 83 | 32 | 3 | CID011968896 | |
| Drug | lead stearate | 2.22e-04 | 84 | 32 | 3 | CID000061258 | |
| Drug | alpha-chaconine | 2.27e-04 | 16 | 32 | 2 | CID000104750 | |
| Drug | NSC 714187 | 2.30e-04 | 85 | 32 | 3 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 2.38e-04 | 86 | 32 | 3 | CID000001322 | |
| Drug | azoxystrobin | 2.55e-04 | 88 | 32 | 3 | CID003034285 | |
| Drug | ethylnylestradiol | 2.61e-04 | 1251 | 32 | 8 | CID000003285 | |
| Drug | H-9 dihydrochloride | 2.73e-04 | 90 | 32 | 3 | CID000003544 | |
| Drug | chlorobiphenyl | 3.22e-04 | 19 | 32 | 2 | CID000249266 | |
| Drug | quinocetone | 3.89e-04 | 248 | 32 | 4 | ctd:C502851 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.19e-08 | 24 | 32 | 4 | C0887833 | |
| Disease | Glioblastoma | 1.62e-06 | 79 | 32 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.07e-06 | 84 | 32 | 4 | C0334588 | |
| Disease | Glioblastoma Multiforme | 6.29e-06 | 111 | 32 | 4 | C1621958 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.38e-05 | 7 | 32 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.38e-05 | 7 | 32 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 3.61e-05 | 59 | 32 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.61e-05 | 59 | 32 | 3 | C0037286 | |
| Disease | Schizophrenia | 3.67e-05 | 883 | 32 | 7 | C0036341 | |
| Disease | hemangiopericytoma (is_marker_for) | 4.08e-05 | 9 | 32 | 2 | DOID:264 (is_marker_for) | |
| Disease | octadecanedioate measurement | 5.10e-05 | 10 | 32 | 2 | EFO_0021056 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 7.47e-05 | 12 | 32 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 8.40e-05 | 215 | 32 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Migraine Disorders | 8.82e-05 | 13 | 32 | 2 | C0149931 | |
| Disease | Squamous cell carcinoma of esophagus | 1.50e-04 | 95 | 32 | 3 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 1.74e-04 | 100 | 32 | 3 | C0010606 | |
| Disease | Splenomegaly | 2.60e-04 | 22 | 32 | 2 | C0038002 | |
| Disease | congenital heart disease (is_implicated_in) | 3.10e-04 | 24 | 32 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 3.29e-04 | 124 | 32 | 3 | C0007137 | |
| Disease | pallidum volume change measurement, age at assessment | 3.37e-04 | 25 | 32 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | urate measurement | 3.53e-04 | 895 | 32 | 6 | EFO_0004531 | |
| Disease | brain cancer (implicated_via_orthology) | 3.64e-04 | 26 | 32 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Encephalopathies | 3.93e-04 | 27 | 32 | 2 | C0085584 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.23e-04 | 28 | 32 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.86e-04 | 30 | 32 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 5.54e-04 | 32 | 32 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | osteoarthritis (is_marker_for) | 6.63e-04 | 35 | 32 | 2 | DOID:8398 (is_marker_for) | |
| Disease | endometrial cancer (is_marker_for) | 6.63e-04 | 35 | 32 | 2 | DOID:1380 (is_marker_for) | |
| Disease | hematocrit | 6.73e-04 | 1011 | 32 | 6 | EFO_0004348 | |
| Disease | Malignant neoplasm of breast | 9.22e-04 | 1074 | 32 | 6 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNCPSQCNENPVDGH | 631 | Q9H2U9 | |
| ANPNNNLINCAAAGS | 676 | Q8WUJ3 | |
| SQAPGNQRPNNTCCF | 16 | Q9UGC6 | |
| DCASNPCQNGGVCNP | 4016 | Q14517 | |
| PNCQTNINECASNPC | 786 | P46531 | |
| NINECASNPCLNQGT | 791 | P46531 | |
| QFASCENNPCGNGAT | 2371 | Q5T1H1 | |
| LPGACNIPANVSNCN | 31 | Q15323 | |
| VDNPGCNEVNSVNCN | 201 | Q14643 | |
| CANNSTCTVNQGNQP | 4276 | Q07954 | |
| CPCPSSGDEQQQQQQ | 21 | Q9UGI6 | |
| NDCDPNPCLNGGSCQ | 851 | Q9UM47 | |
| APSPSSQSCTANCNQ | 661 | Q96BD5 | |
| LPGACNIPANVSNCN | 31 | O76009 | |
| PQCRICNQNSSNPNQ | 81 | P24043 | |
| SNACNQPTHPNGDCS | 971 | P98164 | |
| NNPQAQQGCSCGSSF | 136 | Q86U28 | |
| DGCQNNCPACTPGQA | 651 | Q9Y6R7 | |
| QNCCPQLQEHSQQPC | 201 | Q96C10 | |
| CNNTANGPTTINNNC | 11 | Q12926 | |
| QCNENLPSSPGYNSC | 36 | O60381 | |
| PCQCNNNVDPSASGN | 516 | Q13753 | |
| CLPSPGNAQAQCTNG | 16 | Q9UBX5 | |
| PNPCQNGAQCYNRAS | 531 | P78504 | |
| TNINDCSQNPCHNGG | 666 | P78504 | |
| QLNCSNSCPQPQNSS | 66 | Q14773 | |
| DPCQNAQLCQNGGSC | 66 | Q99466 | |
| NPDNCVSHQCQNGGT | 276 | Q99466 | |
| RSSPCANGGQCQDQP | 556 | Q99466 | |
| NVPGNCSENPCQNGG | 1306 | Q8TER0 | |
| NTLQCNASGCPAQDP | 406 | Q7RTX0 | |
| TQTGPNQAACNCLPA | 1531 | Q8WWQ8 | |
| GDACDNCPNVPNNDQ | 536 | P49746 | |
| SSPCQNQGTCHNDPL | 931 | O75093 | |
| CQNGANCVDQGNRPV | 1136 | O75093 | |
| LPGACNIPANVSNCN | 31 | Q14525 | |
| PCHQCQCSGNVDPNA | 806 | Q9Y6N6 |